1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Evento
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/46344
Full metadata record
DC FieldValueLanguage
dc.creatorCassia Cristina Pinto Mendicinopt_BR
dc.creatorLeticia Penna Bragapt_BR
dc.creatorLeonardo Vinicius Dias da Silvapt_BR
dc.creatorMenezes de Paduapt_BR
dc.date.accessioned2022-10-18T22:28:55Z-
dc.date.available2022-10-18T22:28:55Z-
dc.date.issued2017-08-22-
dc.citation.issue33pt_BR
dc.citation.spage343pt_BR
dc.citation.epage344pt_BR
dc.identifier.doihttps://doi.org/10.1002/pds.4275pt_BR
dc.identifier.issn1099-1557pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/46344-
dc.description.resumoBackground: Brazilian HIV/AIDS therapeutic guidelines are reviewed regularly to provide updated guidance on antiretroviral treatment of people living with HIV. Antiretroviral regimens are highly effective for managing disease and preventing HIV dissemination. Thus, to evaluate the appropriateness of their use is crucial. Objectives: Describe the profile of dispensing of antiretroviral regimens and the adherence to Brazilian therapeutic guidelines for HIV treatment in adults. Methods: Retrospective analysis of dispensing data of antiretroviral drugs from HIV/AIDS public referral centres in Minas Gerais state, Brazil. Data from the Medication Logistics Control System from 2014 to 2016 were reviewed. Antiretroviral regimens were classified into five categories according to 2014/2015 Brazilian guidelines: first line regimen – FLR, second line regimen – SLR, salvage therapy – ST, other regimens – OR and non-recommended regimen – NRR. Results: A total of 917,754 antiretroviral regimens (equivalent to 696 different combinations and 42,302 patients) were dispensed: 60.3% FLR, 16.9% SLR, 3.2% ST, 19.3% OR and 0.3% NRR, being FLR, SLR and ST in accordance with the guidelines. FLR and SLR included most frequently combinations of tenofovir (or zidovudine) + lamivudine + efavirenz (90.1%), and tenofovir (or zidovudine) + lamivudine + boosted-atazanavir (87.1%), respectively. Raltegravir and boosted-darunavir were the most frequent drugs used in ST (89.3%). Roughly 67% (193/289 combinations) of the OR comprised tenofovir (or zidovudine) + lamivudine + unboosted-lovinapir combinations. NRR included tenofovir + didanosine associations (43.6%), which could lead to pancreatitis and lactic acidosis. Virologic effectiveness of darunavir- or saquinavirbased regimens would be prevented in 22.6% of NRR as these antiretroviral drugs were contained in unboosted preparations. Conclusions: While demonstrating high agreement with the national guidelines, the findings also showed a considerable rate of OR and NNR. This highlights the need for increased vigilance of dispensing of antiretroviral drugs in order to provide better clinical outcomes.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentFAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOSpt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofInternational Conference on Pharmacoepidemiology & Therapeutic Risk Managementpt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectHIVpt_BR
dc.subjectAIDSpt_BR
dc.subjectTratamentopt_BR
dc.subject.otherHIVpt_BR
dc.subject.otherAIDSpt_BR
dc.subject.otherTratamentopt_BR
dc.titleAdherence to Brazilian HIV-AIDS treatment guidelines: A 3-year retrospective analysis of dispensing datapt_BR
dc.typeArtigo de Eventopt_BR
dc.url.externahttps://onlinelibrary.wiley.com/doi/full/10.1002/pds.4275pt_BR
Appears in Collections:Artigo de Evento

Files in This Item:
File Description SizeFormat 
Adherence to Brazilian HIV-AIDS Treatment Guidelines A 3-Year Retrospective Analysis of Dispensing Data.pdf69.19 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.